Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605302 · ClinicalTrials.gov registry record · NA
Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms
A NA study of Upper Gastrointestinal Symptoms, sponsored by AnX Robotica.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 1
- Study location
NCT04605302: Completed NA study of Upper Gastrointestinal Symptoms, sponsored by AnX Robotica.
NCT04605302 is a NA study of Upper Gastrointestinal Symptoms that has completed, run by AnX Robotica. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04605302, a NA study of Upper Gastrointestinal Symptoms, has completed, sponsored by AnX Robotica.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective single blinded, tandem study, comparing a magnetically controlled capsule with or without a tether (MCC or MCC-T) with conventional upper endoscopy for the diagnosis of patients with upper abdominal symptoms.
Primary Outcome
A count of the cumulative total number of lesions identified by the MCCE procedure versus a count of the cumulative total number of lesions identified by the EGD procedure.
Conditions Studied
Interventions
- DEVICE MCC/MCC-T
- DEVICE Standard gastroscopy
Study Locations (1)
Massachusetts
- University of Massachusetts Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
What the finished NCT04605302 record still lists
NCT04605302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Upper Gastrointestinal Symptoms appearing as the primary indexed condition, and to 2 interventions - of which MCC/MCC-T is the first listed.
NCT04605302 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04605302 about?
NCT04605302 is a clinical study titled "Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms". A prospective single blinded, tandem study, comparing a magnetically controlled capsule with or without a tether (MCC or MCC-T) with conventional upper endoscopy for the diagnosis of patients with upper abdominal symptoms.
What is the current status of trial NCT04605302?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2021-02-10. Estimated completion is 2023-03-30.
What conditions does trial NCT04605302 study?
This clinical trial studies the following conditions: Upper Gastrointestinal Symptoms.
What interventions are being tested in trial NCT04605302?
The interventions under investigation include: MCC/MCC-T (DEVICE), Standard gastroscopy (DEVICE).
Who is sponsoring clinical trial NCT04605302?
This trial is sponsored by AnX Robotica, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04605302 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04605302's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI